Form 4: David E. Lazar Sells Series E Convertible Preferred Stock in OpGen Inc.
SEC Form 4
David E. Lazar, a director, 10% owner, and CEO of OpGen Inc., sold 550,000 shares of Series E Convertible Preferred Stock on July 30, 2024.
Summary
- On July 30, 2024, David E. Lazar sold 550,000 shares of Series E Convertible Preferred Stock of OpGen Inc.
- The sale was made to AEI Capital Group, a third party, under a securities purchase agreement.
- Lazar also sold the rights to acquire an additional 2,450,000 shares of Series E Preferred Stock for $2,450,000, pursuant to an agreement between Lazar and the Company.
- The Series E Preferred Stock is convertible at the option of the Reporting Person for no additional consideration and is perpetual with no expiration date.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The sale of shares by a major shareholder could be interpreted negatively, but without further context, it's difficult to assess the overall impact.
Industry Context
This filing reflects insider trading activity, which is a common occurrence in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's prospects.
Stakeholder Impact
- Shareholders may react to the news of the sale of shares by a major shareholder, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 07/30/2024 | Date of transaction: David E. Lazar sold Series E Convertible Preferred Stock and rights to acquire additional shares. |
| 08/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.